• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Cannabis Market
    Cannabis News
    Cannabis Stocks
    • Cannabis Market
    • Cannabis News
    • Cannabis Stocks
    cannabis investing

    Abattis to Get 90 Percent Interest in Gabriola Green Farms

    Bryan Mc Govern
    Feb. 27, 2018 12:30PM PST
    Cannabis Investing News

    Abattis Bioceuticals announced a new definitive agreement o acquire 90 percent ownership interest in Gabriola Green Farms.

    Abattis Bioceuticals (CSE:ATT; OTC:ATTBF) announced a new definitive agreement to acquire 90 percent ownership interest in Gabriola Green Farms.

    As quoted in the press release:

    Gabriola is a privately held British Columbia company that has applied for a license to produce under the Access to Cannabis for Medical Purposes Regulationson Gabriola Island, one of the gulf islands located in the Strait of Georgia off the coast of British Columbia. Gabriola Island has a consistent temperature and humidity level, which makes it well suited to greenhouse growing.

    “This is one of the most significant steps our Company has taken towards becoming a full service cannabis company,” stated Rob Abenante, Abattis President and CEO. “After successfully obtaining a license through Gabriola, we intend to not only cultivate marijuana, but more importantly sell extracted cannabis products, which will complete our full downstream service offerings.”

    Click here to read the full press release.

    Source: marijuanaindex.com

    cannabis productsabattis bioceuticalscannabis investingbritish columbia
    The Conversation (0)

    Go Deeper

    AI Powered
    BioHarvest Sciences CEO Ilan Sobel

    BioHarvest CEO Ilan Sobel: Disrupting Industries with Unique Products and Therapeutic Solutions

    Abattis Signs Regulatory Services Agreement

    Latest News

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Cannabis Investing News Stocks

    extractX

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×